![Why Europe is no longer a value trap](https://i-invdn-com.investing.com/news/LYNXNPEC5Q0S0_S.jpg)
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.910 | 2.950 | 0.040 |
Stocks | 95.840 | 95.840 | 0.000 |
Other | 1.250 | 1.320 | 0.070 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.834 | 14.655 |
Price to Book | 1.812 | 2.029 |
Price to Sales | 0.996 | 1.326 |
Price to Cash Flow | 7.817 | 9.177 |
Dividend Yield | 3.284 | 3.310 |
5 Years Earnings Growth | 8.828 | 11.859 |
Name | Net % | Category Average |
---|---|---|
Industrials | 29.090 | 20.118 |
Consumer Cyclical | 22.150 | 12.705 |
Basic Materials | 14.120 | 8.426 |
Healthcare | 8.830 | 14.026 |
Consumer Defensive | 8.320 | 9.324 |
Energy | 6.160 | 5.735 |
Financial Services | 6.080 | 14.783 |
Technology | 5.260 | 11.725 |
Number of long holdings: 66
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Babcock International | GB0009697037 | 3.20 | 616.00 | +0.90% | |
Wolters Kluwer | NL0000395903 | 2.87 | 178.70 | -0.78% | |
Next | GB0032089863 | 2.85 | 10,005.0 | -0.10% | |
Microsoft | US5949181045 | 2.73 | 408.43 | -0.51% | |
P&G | US7427181091 | 2.57 | 162.89 | -4.75% | |
Arkema | FR0010313833 | 2.37 | 83.80 | +0.18% | |
Relx | GB00B2B0DG97 | 2.32 | 4,073.00 | -1.50% | |
Accenture | IE00B4BNMY34 | 2.31 | 388.00 | -0.39% | |
Commerzbank | DE000CBK1001 | 2.17 | 19.590 | +1.35% | |
Cie Automotive | ES0105630315 | 2.12 | 24.600 | -0.40% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ES0167974007 | 56.21M | 4.68 | - | - | ||
ES0167986001 | 10.08M | 3.88 | - | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review